For research use only. Not for therapeutic Use.
Axatilimab（Cat No.:I042167）is an investigational monoclonal antibody that targets the immune checkpoint receptor CSF-1R (colony-stimulating factor 1 receptor), which is involved in the regulation of immune cells, particularly macrophages. CSF-1R plays a key role in immune suppression within the tumor microenvironment, allowing cancer cells to evade detection. By inhibiting CSF-1R, axatilimab aims to enhance anti-tumor immunity and improve the effectiveness of cancer treatments. It is being studied in clinical trials for its potential to treat various cancers, including solid tumors, with a focus on improving patient outcomes through immune modulation.
| Catalog Number | I042167 |
| CAS Number | 2155851-88-8 |
| Purity | ≥95% |
